BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26216371)

  • 1. The effects of right ventricular apical pacing with transvenous pacemaker and implantable cardioverter defibrillator on mitral and tricuspid regurgitation.
    Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M
    J Electrocardiol; 2015; 48(5):791-7. PubMed ID: 26216371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction and aggravation of atrioventricular valve regurgitation in the course of chronic right ventricular apical pacing.
    Alizadeh A; Sanati HR; Haji-Karimi M; Yazdi AH; Rad MA; Haghjoo M; Emkanjoo Z
    Europace; 2011 Nov; 13(11):1587-90. PubMed ID: 21742681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pacemaker and implantable cardioverter defibrillator electrodes on tricuspid regurgitation and right sided heart functions.
    Arabi P; Özer N; Ateş AH; Yorgun H; Oto A; Aytemir K
    Cardiol J; 2015; 22(6):637-44. PubMed ID: 26412607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous pacemaker or implantable cardioverter-defibrillator lead removal in an attempt to improve symptomatic tricuspid regurgitation.
    Nazmul MN; Cha YM; Lin G; Asirvatham SJ; Powell BD
    Europace; 2013 Mar; 15(3):409-13. PubMed ID: 23193162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tricuspid Regurgitation Following Implantation of Endocardial Leads: Incidence and Predictors.
    Lee RC; Friedman SE; Kono AT; Greenberg ML; Palac RT
    Pacing Clin Electrophysiol; 2015 Nov; 38(11):1267-74. PubMed ID: 26234305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of transvenous pacemaker and implantable cardioverter defibrillator lead placement on tricuspid valve function: an observational study.
    Kim JB; Spevack DM; Tunick PA; Bullinga JR; Kronzon I; Chinitz LA; Reynolds HR
    J Am Soc Echocardiogr; 2008 Mar; 21(3):284-7. PubMed ID: 17604958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tricuspid regurgitation and implantable devices.
    Al-Bawardy R; Krishnaswamy A; Rajeswaran J; Bhargava M; Wazni O; Wilkoff B; Tuzcu EM; Martin D; Thomas J; Blackstone E; Kapadia S
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):259-66. PubMed ID: 25377489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads.
    Lin G; Nishimura RA; Connolly HM; Dearani JA; Sundt TM; Hayes DL
    J Am Coll Cardiol; 2005 May; 45(10):1672-5. PubMed ID: 15893186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening tricuspid regurgitation associated with permanent pacemaker and implantable cardioverter-defibrillator implantation: A systematic review and meta-analysis of more than 66,000 subjects.
    Alnaimat S; Doyle M; Krishnan K; Biederman RWW
    Heart Rhythm; 2023 Nov; 20(11):1491-1501. PubMed ID: 37506990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Right Ventricular Apical Pacing Frequency on Left Ventricle Function and Pulmonary Artery Pressure.
    Fanari Z; Hammami S; Hammami MB; Hammami S; Shuraih M
    Del Med J; 2015 Aug; 87(8):244-7. PubMed ID: 26402927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Echocardiography-guided Cardiac Implantable Electronic Device Implantation to Reduce Device Related Tricuspid Regurgitation: A Prospective Controlled Study.
    Marincheva G; Levi T; Perelshtein Brezinov O; Valdman A; Rahkovich M; Kogan Y; Laish-Farkash A
    Isr Med Assoc J; 2022 Jan; 24(1):25-32. PubMed ID: 35077042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Worsening tricuspid regurgitation after ICD implantation is rather due to transvenous lead than natural progression.
    Breeman KTN; Peijster AJL; De Bruin-Bon HACM; Pepplinkhuizen S; Van der Stuijt W; De Veld JA; Beurskens NEG; Stuiver MM; Wilde AAM; Tjong FVY; Knops RE
    Int J Cardiol; 2023 Apr; 376():76-80. PubMed ID: 36758860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Right Ventricular Pacing on Right Ventricular Mechanics and Tricuspid Regurgitation in Patients With High-Grade Atrioventricular Block and Sinus Rhythm (from the Protection of Left Ventricular Function During Right Ventricular Pacing Study).
    Saito M; Iannaccone A; Kaye G; Negishi K; Kosmala W; Marwick TH;
    Am J Cardiol; 2015 Dec; 116(12):1875-82. PubMed ID: 26517949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permanent cardiac pacing and its influence on tricuspid valve function.
    Krupa W; Kozłowski D; Derejko P; Swiatecka G
    Folia Morphol (Warsz); 2001 Nov; 60(4):249-57. PubMed ID: 11770335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.
    Höke U; Auger D; Thijssen J; Wolterbeek R; van der Velde ET; Holman ER; Schalij MJ; Bax JJ; Delgado V; Marsan NA
    Heart; 2014 Jun; 100(12):960-8. PubMed ID: 24449717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Leadless Pacemaker Therapy on Cardiac and Atrioventricular Valve Function Through 12 Months of Follow-Up.
    Beurskens NEG; Tjong FVY; de Bruin-Bon RHA; Dasselaar KJ; Kuijt WJ; Wilde AAM; Knops RE
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007124. PubMed ID: 31060371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ventricular pacing lead position on tricuspid regurgitation: A randomized prospective trial.
    Schleifer JW; Pislaru SV; Lin G; Powell BD; Espinosa R; Koestler C; Thome T; Polk L; Li Z; Asirvatham SJ; Cha YM
    Heart Rhythm; 2018 Jul; 15(7):1009-1016. PubMed ID: 29496605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tricuspid regurgitation induced by transvenous right ventricular pacing: echocardiographic and pathological observations].
    Sakai M; Ohkawa S; Ueda K; Kin H; Watanabe C; Matsushita S; Kuramoto K; Sugiura M; Takahashi T; Takenaka K
    J Cardiol; 1987 Jun; 17(2):311-20. PubMed ID: 3448170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revisiting predictors of worse atrioventricular valve and left ventricular systolic function following pacemaker therapy.
    Sasaki K; Togashi D; Nakajima I; Nakayama Y; Harada T; Akashi YJ
    Pacing Clin Electrophysiol; 2023 Dec; 46(12):1643-1651. PubMed ID: 37904603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.